EUVIMEDEUVIMED entdecken
Open Access

Confounding Effects of Tamoxifen: Cautionary and Practical Considerations for the Use of Tamoxifen-Inducible Mouse Models in Atherosclerosis Research—Brief Report

Allison M Dubner iD, Sizhao Lu iD, Austin J Jolly iD, Tysen Noble iD, Tyler Hinthorn, Raphael A Nemenoff, Karen S Moulton iD, Mark W Majesky iD, Mary C M Weiser-Evans iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2023

DOI: 10.1161/atvbaha.123.319922 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023. Verfasst von Allison M Dubner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Renal Diseases and Hypertension (A.M.D., S.L., A.J., T.N., T.H., R.A.N., M.C.M.W.-E.), University of Colorado Ans…. Hauptthemen laut MEDLINE: Hypercholesterolemia, Atherosclerosis, Plaque, Atherosclerotic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In recent years, fate-mapping lineage studies in mouse models have led to major advances in vascular biology by allowing investigators to track specific cell populations in vivo. One of the most frequently used lineage tracing approaches involves tamoxifen-inducible Cre ERT -LoxP systems. However, tamoxifen treatment can also promote effects independent of Cre recombinase activation, many of which have not been fully explored. METHODS: To elucidate off-target effects of tamoxifen, male and female mice were either unmanipulated or injected with tamoxifen or corn oil. All mice received PCSK9 (proprotein convertase subtilisin/kexin type 9)-AAV (adeno-associated virus) injections and a modified Western diet to induce hypercholesterolemia. After 2 weeks, serum cholesterol and liver morphology were assessed. To determine the duration of any tamoxifen effects in long-term atherosclerosis experiments, mice received either 12 days of tamoxifen at baseline or 12 days plus 2 sets of 5-day tamoxifen boosters; all mice received PCSK9-AAV injections and a modified Western diet to induce hypercholesterolemia. After 24 weeks, serum cholesterol and aortic sinus plaque burden were measured. RESULTS: After 2 weeks of atherogenic treatment, mice injected with tamoxifen demonstrated significantly reduced serum cholesterol levels compared with uninjected- or corn oil–treated mice. However, there were no differences in PCSK9-mediated knockdown of LDL (low-density lipoprotein) receptors between the groups. Additionally, tamoxifen-treated mice exhibited significantly increased hepatic lipid accumulation compared with the other groups. Finally, the effects of tamoxifen remained for at least 8 weeks after completion of injections, with mice demonstrating persistent decreased serum cholesterol and impaired atherosclerotic plaque formation. CONCLUSIONS: In this study, we establish that tamoxifen administration results in decreased serum cholesterol, decreased plaque formation, and increased hepatic lipid accumulation. These alterations represent significant confounding variables in atherosclerosis research, and we urge future investigators to take these findings into consideration when planning and executing their own atherosclerosis experiments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercholesterolemiaAtherosclerosisPlaque, AtheroscleroticMaleFemaleMiceAnimalsProprotein Convertase 9Corn OilReceptors, LDLCholesterolMice, Inbred C57BL

Stichwörter der Autor:innen

corn oilhypercholesterolemialipoproteinsplaquetamoxifen

Substanzen

PCSK9 protein, humanProprotein Convertase 9Corn OilReceptors, LDLCholesterol

Autor:innen und Institutionen

  • Department of Medicine, Division of Renal Diseases and Hypertension (A.M.D., S.L., A.J., T.N., T.H., R.A.N., M.C.M.W.-E.), University of Colorado Anschutz Medical Campus, Aurora.
  • Integrated Physiology PhD Program (A.M.D., M.C.M.W.-E.), Anschutz Medical Campus, Aurora.
  • School of Medicine, Consortium for Fibrosis Research and Translation (S.L., R.A.N., M.C.M.W.-E.), University of Colorado Anschutz Medical Campus, Aurora.
  • Medical Scientist Training Program, University of Colorado School of Medicine (A.J.J., M.C.M.W.-E.), Anschutz Medical Campus, Aurora.
  • Biomedical Sciences and Biotechnology MS program, University of Colorado Graduate School (T.N., T.H.), Anschutz Medical Campus, Aurora.
  • Department of Medicine, Division of Cardiology (K.S.M.), University of Colorado Anschutz Medical Campus, Aurora.

ORCID-Profile: Allison M Dubner, Sizhao Lu, Austin J Jolly, Tysen Noble, Karen S Moulton, Mark W Majesky, Mary C M Weiser-Evans

Förderung

  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NCI NIH HHS

Zitieren

APA

Dubner, A. M., Lu, S., Jolly, A. J., Noble, T., Hinthorn, T., Nemenoff, R. A., Moulton, K. S., Majesky, M. W., & Weiser-Evans, M. C. M. (2023). Confounding Effects of Tamoxifen: Cautionary and Practical Considerations for the Use of Tamoxifen-Inducible Mouse Models in Atherosclerosis Research—Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.319922

Vancouver

Dubner AM, Lu S, Jolly AJ, Noble T, Hinthorn T, Nemenoff RA, et al. Confounding Effects of Tamoxifen: Cautionary and Practical Considerations for the Use of Tamoxifen-Inducible Mouse Models in Atherosclerosis Research—Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023. doi:10.1161/atvbaha.123.319922

BibTeX
@article{Dubner2023,
  author = {Dubner, Allison M and Lu, Sizhao and Jolly, Austin J and Noble, Tysen and Hinthorn, Tyler and Nemenoff, Raphael A and Moulton, Karen S and Majesky, Mark W and Weiser-Evans, Mary C M},
  title = {Confounding Effects of Tamoxifen: Cautionary and Practical Considerations for the Use of Tamoxifen-Inducible Mouse Models in Atherosclerosis Research—Brief Report},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2023},
  doi = {10.1161/atvbaha.123.319922}
}
Kostenlos starten →